Name: ADPT Income Statement - Adaptive Biotechnologies Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

ADPT - Adaptive Biotechnologies Corp.

USD | NASDAQ | Healthcare

ADPT Income Statement - Adaptive Biotechnologies Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q3 FY 18	Q2 FY 18
Revenues
Revenues	70.9	71.7	94.0	58.9	52.4	47.5	46.4	43.2	41.9	45.8	37.9	48.9	37.6	55.2	47.8	43.7

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017
Revenues
Revenues	295.4	277.0	179.0	170.3	185.3	154.3	98.4	85.1	55.7	38.4
Cost of Revenue	73.1	71.4	72.1	75.6	57.9	49.3	22.5	22.3	19.7	15.7
Gross Profit	222.3	205.6	106.9	94.7	127.4	105.0	75.9	62.8	36.0	22.8
Operating Expenses
Research & Development	93.2	93.8	103.0	122.1	141.8	142.3	116.1	70.7	39.2	32.0
Selling General & Administrative	-	-	-
Operating Income
Operating Income	(46.7)	(57.1)	(162.5)	(227.0)	(200.2)	(209.0)	(152.8)	(78.4)	(49.8)	(44.5)
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-
Interest Expense	11.8	11.8	11.6	13.8
Tax & Net
Income Tax Expense	-	0.0	0.0	0.0	-	-	-	-	-	-
Net Income From Continuing Ops	(49.6)	(59.5)	(159.6)
Per Share
EPS Basic	(0.32)	(0.39)	(1.08)	(1.56)	(1.40)	(1.48)	(1.11)	-	-	-
EPS Diluted	(0.32)	(0.39)	(1.08)	(1.56)
Supplementary Data
EBITDA	(31.6)	(41.1)	(145.1)	(207.4)	(179.3)	(196.7)	(146.0)	(72.3)	(45.5)	(40.4)
EBIT	(46.7)	(57.1)	(162.5)	(227.0)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	23.6	21.8	23.7	24.1	24.2	23.2	24.2	25.4	30.2	28.7	28.5	32.2	32.6	31.2	35.7	37.0	37.8	34.7	36.1	37.8	33.8	35.8	30.3	26.0	23.9	21.2	20.5	16.5	12.5	9.8	9.5
Selling General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling & Marketing	26.3	24.5	23.5	23.6	23.0	21.6	20.6	20.3	22.3	21.9	20.5	23.9	22.3	23.7	21.5	24.3	26.1
General & Administrative	21.0	19.6	18.0	17.8	17.4	18.1	17.3	17.9	19.6	20.7	20.1	22.3	20.8	22.4	20.8	21.2	24.1
Depreciation & Amortization	3.4	3.7	4.0	4.1	4.3	3.5	4.2	4.6	5.2	2.8	5.8	5.7	5.4	-	-	-
Amortization of Intangibles	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	90.1	84.5	83.7	83.9	82.0	81.3	79.1	90.5	90.6	116.9	88.9	96.7	94.8	94.4	93.3	96.2

Operating Income
Operating Income	(19.2)	(12.8)	10.3	(25.0)	(29.6)	(33.8)	(32.6)	(47.3)	(48.8)	(71.1)	(51.0)	(47.8)	(57.2)	(39.2)	(45.4)	(52.5)	(63.1)	(61.6)	(56.3)	(49.8)	(41.3)	(44.2)	(37.0)	(36.9)	(34.6)	(24.2)	(18.1)	(16.1)	(20.0)	(9.2)	(13.3)

Tax & Net
Income Tax Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.7	(1.5)	(0.3)	-	-	-	-	-	-
Net Income From Continuing Ops	(20.0)	(13.6)	9.5	(25.6)	(29.8)	(33.7)	(32.1)	(46.2)	(47.5)	(69.5)	(50.3)	(47.8)	(57.7)	(40.2)	(45.3)	(52.1)	(62.8)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	(20.0)	(13.6)	9.5	(25.6)	(29.8)	(33.7)	(32.1)	(46.2)	(47.5)	(69.5)	(50.3)	(47.8)	(57.7)	(40.2)	(45.3)	(52.1)	(62.8)
Net Income Attributable To Parent	(20.0)	(13.6)	9.5	(25.6)	(29.9)	(33.7)	(32.1)	(46.2)	(47.5)	(69.4)	(50.3)	(47.8)	(57.7)	(40.1)	(45.3)	(52.0)
Less: Minority Interest	0.0	0.0	(0.0)	0.0	0.0	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.0)	(0.1)
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	(20.0)	(13.6)	9.5	(25.6)	(29.9)	(33.7)	(32.1)	(46.2)	(47.5)	(69.4)	(50.3)	(47.8)	(57.7)	(40.1)	(45.3)

Per Share
EPS Basic	(0.13)	-	0.06	(0.17)	(0.20)	-	(0.22)	(0.31)	(0.33)	-	(0.35)	(0.33)	(0.40)	-	(0.32)	(0.37)	(0.44)	-	(0.40)	(0.35)	-	-	-	-	-	-	-	-	-	-	-
EPS Diluted	(0.13)	-	0.06	(0.17)	(0.20)	-	(0.22)	(0.31)	(0.33)	-	(0.35)	(0.33)	(0.40)	-	(0.32)	(0.37)	(0.44)	-
Shares Basic	155.5	-	152.4	152.1	149.2	-	147.5	147.4	145.8	-	144.7	144.4	143.5	-	142.9	142.4	141.7	-
Shares Diluted	155.5	-	163.2	152.1	149.2	-	147.5	147.4	145.8	-	144.7	144.4	143.5	-	142.9	142.4	141.7	-

Supplementary Data
EBITDA	(15.8)	(9.1)	14.3	(21.0)	(25.3)	(30.3)	(28.5)	(42.7)	(43.5)	(68.3)	(45.2)	(42.2)	(51.8)	-	-	-	(58.4)	-	-	-	(39.0)	-	-	-	(33.1)	-	-	-	(18.7)	-	-
EBIT	(19.2)	(12.8)	10.3	(25.0)	(29.6)	(33.8)	(32.6)	(47.3)	(48.8)	(71.1)	(51.0)	(47.8)	(57.2)	(39.2)	(45.4)	(52.5)	(63.1)	(61.6)	(56.3)

Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	2.9	3.0	3.0	2.9	2.9	3.0	2.9	2.7	3.0	3.0	3.7	3.6	3.5	-	0.7	-	-	-
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Pre-Tax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-